64 results
8-K
EX-99.2
tnghnh d6
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
SC 14D9
8v8jbyw9eims33 b1v
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
8qglmr7cv538mbt
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-99.2
i3x8rrest
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
qzk3 bzsmwp6gk2
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K/A
EX-99.1
6bjxq22s 2wymktgj
16 Nov 21
Results of Operations and Financial Condition
6:30am
8-K
EX-99.2
yvauoofl68xb af
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am
8-K
EX-99.2
0jouo31k
6 May 21
TherapeuticsMD Announces First Quarter 2021 Financial Results
7:00am